Document Detail


Treatment of hypertension and ischemic heart disease.
MedLine Citation:
PMID:  2483226     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiovascular morbidity and mortality increase as a function of blood pressure, but antihypertensive treatment reduces the rate of both events, thereby representing a preventive means against hypertension-related complications. This prevention, however, does not entirely normalize the risk and appears to be ineffective or only slightly effective against coronary artery disease. This paper reviews the hypotheses that have been advanced to explain the inability of antihypertensive treatment to offer less than complete protection and to provide primary cardioprotection, with emphasis on (a) the lack of full blood pressure control in a large fraction of the hypertensive population, (b) the excessive blood pressure reduction in subjects with ischemic heart disease and dependence of coronary perfusion from a relatively high blood pressure value, and (c) the multifactorial risk profile of coronary artery disease that may make blood pressure reduction alone insufficient in many patients. The last hypothesis is discussed also in relation to the best possible intervention approach to hypertension and to the choice of the antihypertensive agents that may make primary cardioprotection possible.
Authors:
G Mancia
Related Documents :
16211196 - Screening for hypertension in high school.
16004856 - Population strategies to treat hypertension.
629496 - Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and...
17825166 - Microalbuminuria associated with systolic blood pressure and arterial compliance in chi...
10679506 - Attenuation of the "white-coat effect" by antihypertensive treatment and regression of ...
12147526 - Inhibitory effects of high pressure and heat on alicyclobacillus acidoterrestris spores...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  14 Suppl 9     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1989  
Date Detail:
Created Date:  1990-04-09     Completed Date:  1990-04-09     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S12-9     Citation Subset:  IM    
Affiliation:
Cattedra di Semeiotica Medica, Università di Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antihypertensive Agents / therapeutic use*
Coronary Disease / etiology*,  prevention & control
Humans
Hypertension / complications*,  drug therapy
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute consequences of ischemic myocardial damage.
Next Document:  The adrenergic system and prevention of myocardial damage by beta-blockade: a clinical overview.